The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 330:1617 June 2, 1994 Number 22
NextNext

Hemophilia A

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Hoyer, L. W.
To the Editor: Although Dr. Hoyer has written a comprehensive review of the medical aspects of hemophilia (Jan. 6 issue),1 the review does not address the effect on patients of blood products contaminated with the human immunodeficiency virus (HIV). The contamination of the blood supply with HIV was the greatest iatrogenic catastrophe in history. Over 7000 people with coagulation disorders were infected between 1979 and 1985, until virally inactivated clotting-factor concentrates were widely introduced2; over 2000 people have died already, and the remainder will eventually have total immune dysfunction3. Hundreds of sexual partners and children were unwittingly infected . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.